#	Pagina
attuale pagina	/open-h2020/projects/197359/index.html

Opendata, web and dolomites

BLACANDI

BLACANDI can improve life quality and cut cost of diagnosing and managing bladder cancer in half

Total Cost €

EC-Contrib. €

Partnership

Views

Outcomes and
results

BLACANDI project word cloud

Explore the words cloud of the BLACANDI project. It provides you a very rough idea of what is the project "BLACANDI" about.

opportunity biomarkers maturation sme licensed substituting lifetime coupled expensive preliminary dramatically billion patented care blood 6th substitute worldwide denmark patient solution clinical pp cells danish whereas diagnosis invasive solutions business tested blacandi expression combination 357 performed highest cut inexpensive customization 180 aps enhances diagnosing patients urine cystoscopy demonstrated save 900 trial burden recurrence cancer tests provides routine strategy small relapsing indicate bladder validation corroborate enormous commercial diagnostics poses 90 feasibility hematuria hampered device absence cancers treatment million tumor nature filtration health presenting incidence genomic half

Project "BLACANDI" data sheet

The following table provides information about the project.

Coordinator	GENOMIC EXPRESSION APS Organization address address: BORGSKRIVERVEJ 3 2 TH city: KOBENHAVN NV postcode: 2400 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.
Coordinator Country	Denmark [DK]
Project website	http://www.genomicexpression.com
Total cost	71˙429 €
EC max contribution	50˙000 € (70%)
Programme	1. H2020-EU.3.1.3. (Treating and managing disease)
Code Call	H2020-SMEINST-1-2014
Funding Scheme	SME-1
Starting year	2015
Duration (year-month-day)	from 2015-07-01 to 2015-12-31

Partnership

Take a look of project's partnership.

#	participants	country	role	EC contrib. [€]
1	GENOMIC EXPRESSION APS GENOMIC EXPRESSION APS Organization address address: BORGSKRIVERVEJ 3 2 TH city: KOBENHAVN NV postcode: 2400 website: n.a. contact info title: n.a. name: n.a. surname: n.a. function: n.a. email: n.a. telephone: n.a. fax: n.a.	DK (KOBENHAVN NV)	coordinator	50˙000.00

Map

Project objective

The BLACANDI project aims to dramatically improve the diagnosis and management of bladder cancer patients by substituting a highly invasive and expensive test with a non-invasive and inexpensive test. Bladder cancer is the 6th most common cancer with an estimated 357,000 new cases worldwide every year, of which 180,000 are European. This type of cancer has the highest lifetime treatment costs per patient (pp) of all cancers. This high incidence, coupled with it’s relapsing nature, means that bladder cancer poses an enormous burden on health care systems. Current diagnostics and recurrence routine tests are performed through highly invasive and expensive procedures, such as cystoscopy. The Danish SME Genomic Expression Aps has licensed a technology composed of a patented filtration device that enhances the selection of tumor cells in urine, and aims at the clinical validation of a new combination of biomarkers.

Our solution BLACANDI (Filtration Device in combination with selected biomarkers) is currently being tested in a small clinical trial in Denmark, in patients presenting with hematuria (blood in urine). Preliminary results indicate that the test can substitute cystoscopy identifying more than 90% of all bladder cancer patients.

Substituting routine cystoscopy with the BLACANDI system could cut the cost of diagnosis and managing bladder cancer in half. In Europe the cost of diagnosing bladder cancer is €1.8 billion/year, thus we could save €900 million.

Whereas the technology behind the filtration device and the selected biomarkers is already demonstrated, further maturation of the tests into fully commercial and operational solutions is hampered by the absence of a large clinical validation of the BLACANDI system.

Furthermore, there is a need to corroborate our business strategy, since it requires customization to different health care systems. This phase 1 feasibility study provides us that opportunity.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BLACANDI" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BLACANDI" are provided by the European Opendata Portal: CORDIS opendata.